Skip to main content
C

Charmacy Pharmaceutical Co., Ltd. — Investor Relations & Filings

Ticker · 2289 HKEX Wholesale and retail trade
Open in API
Filings indexed 509 across all filing types
Latest filing 2026-03-02 Regulatory Filings
Country HK Hong Kong
Listing HKEX 2289

About Charmacy Pharmaceutical Co., Ltd.

http://www.chmyy.com

Charmacy Pharmaceutical Co., Ltd. is a leading pharmaceutical distribution company operating primarily in Southern China (Guangdong, Fujian, Guangxi, and Hainan). The core business involves distributing a comprehensive range of products, including Western medicines, Chinese patent medicines, and healthcare products, primarily targeting downstream distributors and retail terminal customers (chemists). The company specializes in the non-tender pharmaceutical market, where it holds a leading position. Additionally, Charmacy provides value-added services such as third-party logistics (3PL) and pharmaceutical product consultation, supported by modern distribution centers in key cities like Shantou, Guangzhou, and Shenzhen.

Recent filings

Filing Released Lang Actions
Monthly Return of Equity Issuer on Movements in Securities for the month ended 28 February 2026
Regulatory Filings Classification · 1% confidence The document is a 'Monthly Return for Equity Issuer' (Form FF301) filed with the Hong Kong Stock Exchange (HKEX). This form is a standard regulatory requirement for listed companies in Hong Kong to report monthly movements in securities, share capital, and public float. Since it does not fit into specific categories like 'Share Issue' (which would be a specific event) or 'Annual Report', and it is a mandatory regulatory filing for ongoing compliance, it is best classified as a Regulatory Filing (RNS).
2026-03-02 English
Monthly Return of Equity Issuer on Movements in Securities for the month ended 31 January 2026
Share Issue/Capital Change Classification · 1% confidence The document is a 'Monthly Return for Equity Issuer' (Form FF301) filed with the Hong Kong Stock Exchange (HKEX). This form is a standard regulatory requirement for listed companies to report movements in securities, share capital, and public float status on a monthly basis. Since it details changes in share capital and securities, it falls under the category of share/capital changes.
2026-02-02 English
Monthly Return of Equity Issuer on Movements in Securities for the month ended 31 December 2025
Share Issue/Capital Change Classification · 1% confidence The document is a 'Monthly Return for Equity Issuer' (Form FF301) filed with the Hong Kong Stock Exchange (HKEX). This form is a standard regulatory requirement for listed companies in Hong Kong to report monthly movements in securities, share capital, and treasury shares. It does not fit into specific categories like 'Share Issue' (SHA) or 'Transaction in Own Shares' (POS) because it is a recurring regulatory reporting template covering all movements (or lack thereof) for the month. Therefore, it is best classified as a Regulatory Filing (RNS).
2026-01-05 English
ARTICLES OF ASSOCIATION
Governance Information Classification · 1% confidence The document is the 'Articles of Association' for Charmacy Pharmaceutical Co., Ltd. This document outlines the company's internal governance, share structure, business objectives, and board/management responsibilities. In the context of corporate filings, the Articles of Association are a foundational governance document that defines the company's legal framework and is typically categorized under Governance Information.
2025-12-12 English
POLL RESULTS OF THE EXTRAORDINARY GENERAL MEETING HELD ON 12 DECEMBER 2025&#x3b; CHANGE OF AUDITORS&#x3b; ABOLISHMENT OF THE BOARD OF SUPERVISORS&#x3b; AND AMENDMENTS TO THE ARTICLES OF ASSOCIATION AN
Declaration of Voting Results & Voting Rights Announcements Classification · 1% confidence The document is an official announcement detailing the results of an Extraordinary General Meeting (EGM). It provides a breakdown of poll results for ordinary and special resolutions, including voting percentages and attendance. It also confirms the outcome of specific agenda items such as the change of auditors, the abolishment of the Board of Supervisors, and amendments to the Articles of Association. This aligns perfectly with the definition of a Declaration of Voting Results & Voting Rights Announcement.
2025-12-12 English
Monthly Return of Equity Issuer on Movements in Securities for the month ended 30 November 2025
Share Issue/Capital Change Classification · 1% confidence The document is a 'Monthly Return for Equity Issuer' (Form FF301) filed with the Hong Kong Stock Exchange (HKEX). This form is a standard regulatory requirement for listed companies in Hong Kong to report monthly movements in securities, including share capital, issued shares, and treasury shares. Since it details the status of share capital and movements in securities, it falls under the category of 'Share Issue/Capital Change' (SHA).
2025-12-01 English

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.